Introduction
This live virtual CME accredited symposium features world-renowned experts who will explore recent advancements in oral anticoagulation therapy and Left Atrial Appendage Closure (LAAC) for managing Atrial Fibrillation related stroke over the course of 2 live virtual symposium sessions.
Each live virtual symposium transmission includes a Q&A Session at the immediate conclusion of the presentations.
Live Virtual Symposium Dates, Times and Registration
Session I: LAA Closure for Stroke Prevention
March 30, 2020 | 5:00PM Eastern Standard Time
Register>>
Session II: AF-Related Stroke & Anticoagulation
March 31, 2020 | 5:00PM Eastern Standard Time
Register>>
Agenda
|
Agenda |
|
Session I: LAA Closure for Stroke Prevention Left Atrial Appendage Closure for Stroke Prevention in NVAF: What is the Newest Data? Next-Generation LAA Closure Devices NOACs vs Warfarin: The Stroke Neurologist’s Perspective Recorded Case: Watchman Implantation |
|
Session II: AF-Related Stroke & Anticoagulation Top 10 New Concepts in AF Management Device-Detected Atrial Fibrillation: Who should receive (N)OACs in 2020? Can Wearables Devices Guide Atrial Fibrillation Management? Panel Discussion |
Commercial Support
This activity is being supported through an educational grant from Boston Scientific.
Joint Providership
MediaSphere Medical, LLC and Ciné-Med
Faculty
|
Program Director |
|
Vivek Reddy, MD |
|
Faculty |
||
|
Srinivas Dukkipati, MD Valentin Fuster, MD, PhD, MACC Edip Gurol, MD, MSc |
Taya Glotzer, MD, FACC, FHRS Saibal Kar, MD, FACC, FSCAI Mintu Turakhia, MD, MAS |
CME Accreditation
Session I: CME Released: 3/30/2020; Valid for credit through 3/30/2021
Session II: CME Released: 3/31/2020; Valid for credit through 3/31/2021
CME Certificate Fulfillment
In order to claim your CME/CE credits, access the Earn CME Credit Tab upon the immediate conclusion of the virtual symposium and complete the post-activity CME evaluation form. A certificate will be emailed upon successful completion.
Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, interventional cardiologists, cardiologists, surgeons, neurologists, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
Session I: LAA Closure for Stroke Prevention
- Assess LAAC for stroke prevention in NVAF, including newest data.
- Evaluate next-generation LAAC devices.
- Assess optimal techniques and technologies in LACC.
- Review NOACs vs Warfarin.
Session II: AF-Related Stroke & Anticoagulation
- Evaluate new developments in AF management.
- Review device-detected AF and who should receive (N)OACs.
- Assess the effectiveness of wearable devices for guiding AF management.
Activity Goal
This activity is designed to address the following core and team competencies:
Patient Care, Medical Knowledge, Practice-based learning and improvement, Interprofessional Collaboration, and Roles & Responsibilities.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Session I: LAA Closure for Stroke Prevention
Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Ciné-Med designates this activity for 1 Contact Hours for nurses.
Session II: AF-Related Stroke & Anticoagulation
Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Ciné-Med designates this activity for 1 Contact Hours for nurses.
Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.
It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.
MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.
Educational support provided by:
Boston Scientific